An intestinal bacterial metabolite (M1) of ginseng protopanaxadiol saponins inhibits tumor-induced neovascularization

An intestinal bacterial metabolite (M1) of ginseng protopanaxadiol saponins inhibits tumor-induced neovascularization

Loading...

Taking too long?

Reload document

|

Open in new tab

Kyo Uchida2017-03-07T20:18:07+00:00Cancer, Fermented Ginseng Studies|

This website uses cookies and third party services. By using this website, you agree to the collection and use of information in accordance with our Privacy Policy. Ok